Yes. At Bristol Myers Squibb Sam owned the enterprise generative-AI portfolio for a global Medical Affairs organization, a production RAG platform serving ~2,000 users across 50+ markets, governed under GxP and 21 CFR Part 11.
Yes. He shipped and governed a production retrieval-augmented generation platform serving ~2,000 users across 50+ markets inside an ~$8M annual GenAI and digital portfolio at Bristol Myers Squibb.
He is hands-on; a technical peer confirmed he worked in the code on retrieval-augmented generation, ranking strategies, agentic workflows, and LLM-as-a-judge evaluation, and his public repos include MCP servers, agent harnesses, and a retrieval-evaluation stack in Python and TypeScript.
He is remote-first, based in the Philadelphia metro (Doylestown, PA), is a US citizen, and needs no sponsorship.